Single Dose of Novel Peptide Protects Cognitive Function after Mild Traumatic Brain Injury11-07-2016
Whether at school, in car accidents, on the sports field or the battlefield, mild traumatic brain injury (mTBI) is a common part of our lives. It is especially frequent among children, athletes, and the elderly. Now, scientists at the Hebrew University of Jerusalem have shown that a single dose of a new molecule they developed can effectively protect the brain from inflammation, cell death, and cognitive impairments that often follow a mild traumatic brain injury.
Because it lacks visible external signs or objective structural brain damage, mTBI is an under-diagnosed injury. Yet it is often accompanied by long-lasting cognitive, behavioral and emotional difficulties associated with biochemical and cellular changes. While most symptoms of mTBI are substantially resolved within days or weeks of the injury, up to 50% of mTBI patients experience symptoms at one-year post-injury. These can include psychological symptoms, subjective cognitive impairments, and somatic (physical) complaints.
These changes could result from an increase in glutamate levels, oxidative stress, opening of the blood-brain-barrier, and in particular inflammatory activity followed by cell death (apoptosis).
Currently there is no effective treatment for patients with mTBI.
“It is widely known that external or internal injury strongly activates the inflammatory response and leads to cell death (apoptosis) through the MAPK pathways, which are involved in the cellular responses that lead to inflammation in brain cells,” explains Prof. Daphne Atlas, from the Department of Biological Chemistry in the Alexander Silberman Institute of Life Sciences at the Hebrew University of Jerusalem. “Therefore, for reversing the effects of mTBI it is essential to calm the inflammatory pathways.”
At her laboratory in Jerusalem, Prof. Atlas has developed new molecules derived from the active site of Trx1, called thioredoxin-mimetic peptides (TXM-peptides). Thioredoxin (Trx1) is a major protein that maintains the oxidation/reduction state of the cells. In its reduced form it is bound to another protein (ASK1), which is released upon oxidation of Trx1 and activates a chain of enzymatic reactions that lead to inflammation.
The newly-synthesized thioredoxin-mimetic peptides (TXM-peptides) have been shown to protect cells from early death via the activation of inflammatory pathways. Comprising 3 or 4 amino acids, these peptides have dual activity: they mimic the antioxidant activity of Trx1, and simultaneously inhibit the activity of enzymes called MAPK within the inflammatory pathway, preventing inflammation and cell death.
TXM-CB3 was previously shown to effectively lower MAPK activity in animal models of asthma and in the brain of rat model of diabetes [Kim et al 2011; Bachnoff et al 2011; Cohen-Kutner et al 2013, 2014]. The peptides managed to cross the blood-brain barrier and improve the condition of brain cells by lowering the inflammatory processes.
In the current study, published in the peer-reviewed journal PLOS ONE, Prof. Atlas and colleagues explored the impact of TXM-peptides, TXM-CB3 and TXM-CB13 (DY70; provided by OneDay Biotech and Pharma Ltd), on preventing mTBI cognitive secondary injury. The experiments were performed in collaboration with researchers at Tel Aviv University, Prof. Chagi Pick and Dr. Renana Baratz-Goldstein.
Researchers induced cognitive impairments in anesthetized mice by a weight drop resulting in mild traumatic brain injury. The mice showed a decrease in spatial memory in the Y-maze test and a loss in visual learning ability in the novel object recognition test. Lower learning ability was also detected 30 days post injury in the mTBI mice.
In these two independent tests, a single dose of either one of the TXM-peptides administered 60 minutes post-injury, at a 50 mg per kg of body weight, significantly improved the decline in cognitive performance and learning ability at 7 and 30 days post injury. In addition, the two TXM-peptides were found highly effective at inhibiting the MAPK activity in neuronal cells grown in tissue culture.
“This research demonstrates the potential for TXM-peptides to significantly reduce cognitive impairment after mild traumatic brain injury,” said Prof. Atlas. “Further studies are required to establish and examine the potential of a single dose of TXM-peptide in preventing damage if administered even one hour after brain trauma in human scenarios — for example, in chronic traumatic encephalopathy observed in American football players, which result from multiple concussions and other types of blows to the head.
"Another advantage to using peptides is in significantly reducing the risk of causing toxic effects, because they consist of amino acids which are the natural building blocks comprising cell proteins, in contrast to the use of drugs that are not natural. So TXM-CB3 and TXM-CB13 are promising treatment candidates to prevent secondary damage that affect brain function,” said Prof. Atlas.
Some twenty rectors from leading Latin American universities visited Israel this week and signed agreements with the Hebrew University of Jerusalem, in a first-of-its-kind conference signalling growing academic cooperation15-12-2016
Study of Israeli adolescents also looks at impact of socioeconomic position on subsequent cognitive impairment08-12-2016
Hebrew University Researchers Develop a New Strain of Passion Fruit that significantly protects brain cells and its function from aging-related damage08-12-2016
A history book about Jewish-Arab relations titled Juifs et musulmans en Palestine et en Israel des origines ÃƒÆ’Ã‚Â nos jours recently won the first prize for the best history book published in France in 08-12-2016
Keynote lecture - Child Soldiers06-12-2016
Hebrew University Researchers Bring Home 3 of the 8 EMET Prizes Awarded for 201604-12-2016
When and Why Do Children Give Others the Bigger Piece of the Pie?29-11-2016
Scientists from the Crick Institute, London and the Hebrew University, Jerusalem, discover a protein that plays a key role in turning cancer tumour cells into cancer stem cells that are able to renew outbreaks of the disease22-11-2016
An analysis of graduates employability published by Times Higher Education (THE) has ranked graduates of the Hebrew University of Jerusalem as the 67th most employable in the world.20-11-2016
Governor General discusses collaborative medical research partnerships between Canada and Israel at IMRIC, the Institute for Medical Research Israel-Canada03-11-2016
On the first day of his state visit to Israel, the President of the Italian Republic, Sergio Mattarella, gave a keynote address to an overflow audience, at the Truman Institute on the university's Mount Scopus campus.30-10-2016
Sunday 20th November: 10:30 - 17:00 Paris27-10-2016
Four joint seminars took place, where scientists from the Hebrew University and the University of Vienna met to exchange ideas and to prepare proposals for third party funding27-10-2016
Deborah Steinmetz, Director, Steven Spielberg Jewish Film Archive18-10-2016
International partnership unravels the mechanism by which Hepatitis C Virus (HCV) reprograms human metabolism, and identifies new pathways of anti-viral resistance10-10-2016
Scientists show for the first time how bacterial superantigen toxins work, and how short peptides can block them and save lives06-10-2016
A delegation of Asian religious leaders visited the Hebrew University of Jerusalem13-09-2016
Innovative boutique programme for professional training in the growth, production and analysis of wine, as well as wineries management17-08-2016
Succeeding Jacqueline Caspi as Chair of the BFHU Young Professional Committee is Benjamin Stowe16-08-2016
New finds contribute significantly to research of Roman art in Israel: Provide first evidence of figurative images in wall paintings at the site, and precede earliest mosaics discovered at the site by a hundred years10-08-2016
In a historic find, a large fragment of an Egyptian statue measuring 45 X 40 centimetres, made of lime-stone, was discovered In the course of the current season of excavations at Tel-Hazor, north of the Sea of Galilee in Israel25-07-2016
Dr. Yosef Buganim is a young researcher at the Institute for Medical Research Israel-Canada (IMRIC), part of the Hebrew University's Faculty of Medicine18-07-2016
New molecules, developed by Hebrew University of Jerusalem scientists, reduce inflammation, cell death and cognitive impairments following traumatic brain injury in mice11-07-2016
The Centre for World University Rankings (CWUR), based in Saudi Arabia, has ranked the Hebrew University of Jerusalem at #26 among the 25,000+ degree-granting institutions in the world.11-07-2016
Goes to Hebrew University's ELSC Brain Sciences Centre07-07-2016
Named a Commander of the Legion of Honour29-06-2016
Dame Helen Mirren, one of the world's best-known and most respected actresses, met with Arab and Jewish theatre students at The Billy Crystal Program for Peace Through the Performing Arts26-06-2016
Times Higher Education Asia University Rankings Editor of Times Higher Education Rankings: "It has never been as clear to me that the balance of power is shifting from the West to the East."20-06-2016
Historical survey of excavated mosaic art of pagans, Jews, Samaritans, Christians and Muslims earns Hebrew University professor the first prize in this year's Polonsky Awards08-06-2016
Pinchas Tsukerman developed a novel immunotherapy method in which monoclonal antibodies neutralize the tumor's ability to suppress the immune system07-06-2016
'Striving to expand the government is correct and justified.' President Rivlin, a Hebrew University alumnus, praises academia's role as unifier of Israeli society29-05-2016
The British Friends of The Hebrew University Young Professional Group has held its first dinner. The dinner was hosted by Lord Pannick QC in the Peers' Dining Room, House of Lords26-05-2016
Israeli President Reuven Rivlin, American Jewish Philanthropist Mortimer B. Zuckerman, and i24 founder Patrick Drahi To Be Honored at Hebrew University Convocation22-05-2016
The University of Toronto and The Hebrew University of Jerusalem are pleased to deepen their partnership in the fields of social work and bio-innovation19-05-2016
Hebrew University signs agreements with leading academic institutions from the Republic of Singapore, and confers honorary doctorate upon Prime Minister Lee Hsien Loong18-04-2016
Hebrew University's liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe04-04-2016
Yaacov Michlin, CEO, Yissum: During 2015, Yissum founded a record number of eight companies based on inventions of researchers from the Hebrew University Centre for Nanoscience and Nanotechnology31-03-2016
His Excellency the President of the Hellenic Republic, Mr. Prokopios Pavlopoulos, was awarded an honorary doctorate by the Hebrew University of Jerusalem.30-03-2016
Yissum takes part in project to Operate a Tech Incubator under Israel's National Incubator Programme
Jerusalem Venture Partners (JVP) LED Group joins forces with Motorola Solutions (NYSE: MSI), Reliance Industries (NSE: Reliance) and Yissum, the Research Development Company of the Hebrew University of Jerusalem22-03-2016
The haploid stem cells may yield new genetic screening tools and therapies16-03-2016
New blood test uses methylation patterns of circulating DNA from dying cells to detect diabetes, multiple sclerosis, pancreatic cancer, pancreatitis and brain damage, opening up vast possibilities for diagnostic medicine.14-03-2016
The Technology Transfer Company of the Hebrew University, comes to London10-03-2016
Dedication Ceremony and Memorial Lecture on March 14 on Mount Scopus10-03-2016
Hebrew University students develop life-saving device following a wave of stabbing attacks that leaves some civilians with collapsed lungs09-03-2016
Researchers find that a cell aging program causes human and mouse pancreatic beta cells to work harder and secrete more insulin07-03-2016
Hebrew University researchers develop a solution for long-term preservation of cells and organs for transplant, as part of a global alliance to bank organs02-03-2016
Hebrew University formula that activates the body's natural defense against free radicals could control a variety of skin pathologies and disorders29-02-2016
New fibre optic guide-wire will enable surgeons to perform highly accurate hip fracture and spinal fusion surgery with minimal side effects23-02-2016
Scientists At NSF Press Conference in D.C. Confirm Einstein's Century-Old Prediction11-02-2016
Three-Week Summer Program for International Students and Attorneys Opens June 27, 201608-02-2016
Israeli Minister of Education Naftali Bennett has announced that Prof. Edit Doron will be awarded the Israel Prize for her work in the study of Linguistics.03-02-2016
Over 23,000,000 Euros to Promote Groundbreaking Research in Medicine, Mathematics & Sciences, and the Humanities07-01-2016
Supporting the Hebrew University since 192605-01-2016